Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer
Clinical trial NCT02101580 · COMPLETED
Trial details
- NCT number
- NCT02101580
- Sponsor
- Polaris Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-17
- Primary completion
- 2017-05-05
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.